Masafumi Funamoto

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan

Read more

Articles by Masafumi Funamoto

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats

Hidemichi Takai, Yoichi Sunagawa, Masafumi Funamoto, et al

Published:

Citation: European Cardiology Review 2021;16:e69.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO13
The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats

Yoichi Sunagawa, Ayumi Katayama, Masafumi Funamoto, et al

Published:

Citation: European Cardiology Review 2021;16:e68.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO12
Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay

Satoshi Shimizu, Miho Yamada, Takahiro Katagiri, et al

Published:

Citation: European Cardiology Review 2021;16:e66.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO10
Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice

Yuto Kawase, Kana Shimizu, Masafumi Funamoto, et al

Published:

Citation: European Cardiology Review 2021;16:e57.

DOI:

https://doi.org/10.15420/ecr.2021.16.PO1
Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases

Kana Shimizu, Masafumi Funamoto, Yoichi Sunagawa, et al

Published:

Citation: European Cardiology Review 2019;14(2):117–22

DOI:

https://doi.org/10.15420/ecr.2019.17.2
Erratum to: The Inhibitory Effects of Crucumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine- Induced Responses in Cardiomyocytes

Mai Genpei, Yoichi Sunagawa, Masafumi Funamoto, et al

Citation: European Cardiology Review 2018;13(2):136.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.ER1
Analysis of the Effects of EPA and DHA on Cardiomyocyte hypertrophy

Ayumi Katayama, Masafumi Funamoto, Kana Shimizu, et al

Citation: European Cardiology Review 2018;13(2):121.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO2
The GATA4 Acetylation Site Plays a Key Role in the Development of Cardiomyocyte Hypertrophy

Satoshi Shimizu, Yoichi Sunagawa, Kodai Hara, et al

Citation: European Cardiology Review 2018;13(2):125.

DOI:

https://doi.org/10.15420/ecr.2018.13.2.PO6
Nobiletin a Citrus Flavonoid, Exerts Additional Effects with Angiotensin II Receptor Blocker on Systolic Function in Salt-sensitive Dahl Rats

Haruka Ebi, Masafumi Funamoto, Yoichi Sunagawa, et al

Citation: European Cardiology Review 2017;12(2):92.

DOI:

https://doi.org/10.15420/ecr.2017:23:1
A Novel Target Molecule of Nobiletin Derived from Citrus Peels has a Therapeutic Potency Against the Development of Heart Failure

Yoichi Sunagawa, Masafumi Funamoto, Anna Suzuki, et al

Citation: European Cardiology Review 2017;12(2):105.

DOI:

https://doi.org/10.15420/ecr.2017:23:14
Curcumin Analogue GO-Y030 Significantly Improves Pressure Overload-induced Heart Failure in Vivo

Kana Shimizu, Masafumi Funamoto, Mai Genpei, et al

Citation: European Cardiology Review 2017;12(2):106.

DOI:

https://doi.org/10.15420/ecr.2017:23:15
The Inhibitory Effects of Curcumin Glucuronide on p300-HAT Activity and Hypertrophic Phenylephrine-Induced Responses in Cardiomyocytes

Mai Genpei, Yoichi Sunagawa, Masafumi Funamoto, et al

Citation: European Cardiology Review 2017;12(2):107.

DOI:

https://doi.org/10.15420/ecr.2017:23:16
A Transcriptional Co-activator, p300 is Involved in the Epigenetic Gene Activation on Hypertrophic Response Gene Promoters in Heart Failure

Masafumi Funamoto, Yoichi Sunagawa, Yasufumi Katanasaka, et al

Citation: European Cardiology Review 2017;12(2):110.

DOI:

https://doi.org/10.15420/ecr.2017:23:19